Search research articles
Contact Us
Filters
Showing results (71-80 of 146) with videos related to
Page
of 15
Sort By:
Anticancer Research
|
January 1, 1987
Characterization of multidrug resistance in SEWA mouse tumor cells: increased glutathione transferase activity and reversal of resistance with verapamil
B Dahllöf, T Martinsson, B Mannervik, et al.
Annals of Neurology
|
August 26, 1998
Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles
N Darin, M Kyllerman, J Wahlström, et al.
European Child & Adolescent Psychiatry
|
July 27, 2001
MECP2 mutation screening in Swedish classical Rett syndrome females
A Erlandson, B Hallberg, B Hagberg, et al.
British Journal of Cancer
|
July 17, 1998
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene
K Ejeskär, H Aburatani, J Abrahamsson, et al.
Experimental Cell Research
|
June 1, 1985
Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell line. Complex relations revealed by drug uptake data, and lipid and protein analysis
T Martinsson, B Dahllöf, Y Wettergren, et al.
Clinical Genetics
|
February 1, 1994
Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family
A Oldfors, T Martinsson, I Tessin, et al.
British Journal of Cancer
|
March 1, 2002
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
F Abel, R-M Sjöberg, K Ejeskär, et al.
British Heart Journal
|
October 1, 1994
Dilated cardiomyopathy and the dystrophin gene: an illustrated review
A Oldfors, B O Eriksson, M Kyllerman, et al.
American Journal of Human Genetics
|
April 17, 1999
Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1
T Martinsson, N Darin, M Kyllerman, et al.
Cytogenetics and Cell Genetics
|
July 15, 2000
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors
K Ejeskär, F Abel, R Sjöberg, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 146) with videos related to
Sort By:
Page
of 15
Anticancer Research
|
January 1, 1987
Characterization of multidrug resistance in SEWA mouse tumor cells: increased glutathione transferase activity and reversal of resistance with verapamil
B Dahllöf, T Martinsson, B Mannervik, et al.
Annals of Neurology
|
August 26, 1998
Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles
N Darin, M Kyllerman, J Wahlström, et al.
European Child & Adolescent Psychiatry
|
July 27, 2001
MECP2 mutation screening in Swedish classical Rett syndrome females
A Erlandson, B Hallberg, B Hagberg, et al.
British Journal of Cancer
|
July 17, 1998
Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene
K Ejeskär, H Aburatani, J Abrahamsson, et al.
Experimental Cell Research
|
June 1, 1985
Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell line. Complex relations revealed by drug uptake data, and lipid and protein analysis
T Martinsson, B Dahllöf, Y Wettergren, et al.
Clinical Genetics
|
February 1, 1994
Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family
A Oldfors, T Martinsson, I Tessin, et al.
British Journal of Cancer
|
March 1, 2002
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours
F Abel, R-M Sjöberg, K Ejeskär, et al.
British Heart Journal
|
October 1, 1994
Dilated cardiomyopathy and the dystrophin gene: an illustrated review
A Oldfors, B O Eriksson, M Kyllerman, et al.
American Journal of Human Genetics
|
April 17, 1999
Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1
T Martinsson, N Darin, M Kyllerman, et al.
Cytogenetics and Cell Genetics
|
July 15, 2000
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors
K Ejeskär, F Abel, R Sjöberg, et al.
Page
of 15